drugset
drugset / Trial / NCT00281684

SB-705498 Dental Pain Study After Tooth Extraction

NCT00281684 ↗

Phase 2 Completed 145 enrolled GlaxoSmithKline
RandomizedParallel-groupTreatment

Summary

This clinical trial is a multi centre, randomised, single-blind, parallel group, placebo-controlled, single oral dose study with a positive control arm. Patients previously scheduled for 3rd molar tooth extraction, who are otherwise healthy, will be recruited. Upon completion of surgery, e.g. prior to established pain, patients will be randomised to treatment (SB-706598, placebo or co-codamol) and dosed with the study medication

Timeline

Start
2005-12-07
Primary completion
2007-10-03
Completion
2007-10-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg Oral
Subject Codeine Small molecule 12.8 mg Oral
Subject SB-705498 Small molecule 400 mg Oral
Subject SB-705498 Small molecule 1000 mg Oral

Indications

No indication recorded.